REDUCEDT+30
Amylyx Pharmaceuticals Inc · NASDAQ
−1,042 sh · $34.6K
Filed 14 Sept 2026SEC Form 4view source
- REDUCEDT+30
Amylyx Pharmaceuticals Inc · NASDAQ
−9,768 sh · $315.2K
Filed 14 Sept 2026SEC Form 4view source - ACQUIREDStale
Amylyx Pharmaceuticals Inc · NASDAQ
+22,807 sh
Filed 20 Aug 2026SEC Form 4view source